MFSD6 activators encompass a group of chemical agents that selectively target and enhance the activity of the Major Facilitator Superfamily Domain containing 6 (MFSD6) protein. MFSD6 is a protein that belongs to the major facilitator superfamily (MFS), which is characterized by a diverse group of membrane transport proteins facilitating the movement of a wide array of substrates across cellular membranes. The precise physiological substrates and functions of MFSD6 remain somewhat enigmatic, but it is postulated to be involved in the transport of specific molecules, thereby influencing cellular homeostasis and metabolic processes. Activators of MFSD6 are designed to bind to the protein and induce a conformational change or modulate its transport cycle, with the aim of increasing its intrinsic transport activity. These molecules must adeptly navigate the intricate milieu of the cell membrane, recognizing and engaging with MFSD6 amidst a complex landscape of lipids and other membrane-associated proteins.
The discovery and optimization of MFSD6 activators is a sophisticated endeavor that merges the realms of structural biology, organic chemistry, and pharmacology. The development process typically begins with the elucidation of the protein's structure, either through experimental methods like X-ray crystallography and cryo-electron microscopy or through computational modeling techniques. This structural insight guides the identification of potential activator binding sites, often located within the transmembrane domains or at interfaces that can transmit allosteric effects to the transport mechanism. With these target sites in mind, chemists design and synthesize a variety of compounds, which are then tested for their ability to interact with and activate MFSD6. High-throughput screening methods can be employed to assay large libraries of compounds, while detailed SAR studies refine promising candidates to enhance their potency, selectivity, and ability to engage with MFSD6 effectively. The ultimate aim of these efforts is to produce activators with optimal characteristics to modulate the functional state of MFSD6, thereby influencing its transport activity within the cellular context.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels. Elevated cAMP enhances MFSD6 activity by promoting a cellular environment that favors its transporter function. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $180.00 $726.00 $1055.00 $3350.00 $5200.00 | 23 | |
A-769662 activates AMPK, which can lead to the upregulation of cellular transport processes, including those associated with MFSD6. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $40.00 | 9 | |
Fenofibrate, as a PPARα agonist, modulates lipid metabolism. This can influence the lipid environment of membranes where MFSD6 is active, thereby enhancing its function. | ||||||
GW 3965 hydrochloride | 405911-17-3 | sc-224011 sc-224011A sc-224011B | 5 mg 25 mg 1 g | $137.00 $474.00 $3060.00 | ||
GW3965, by activating LXR, alters cholesterol homeostasis and potentially enhances the functional activity of MFSD6 by affecting the lipid composition of its operational domain. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $32.00 $75.00 $118.00 | 14 | |
FTY720 modulates S1P receptors, which can affect intracellular signaling related to transport mechanisms, potentially enhancing MFSD6 activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 increases intracellular calcium levels, which can stimulate transport and channel-related activities, indirectly enhancing MFSD6 function. | ||||||
GW501516 | 317318-70-0 | sc-202642 sc-202642A | 1 mg 5 mg | $80.00 $175.00 | 28 | |
GW501516 enhances fatty acid metabolism and may indirectly promote MFSD6 transporter activity by affecting lipid profiles within cellular membranes. | ||||||
Sodium nitroprusside dihydrate | 13755-38-9 | sc-203395 sc-203395A sc-203395B | 1 g 5 g 100 g | $42.00 $83.00 $155.00 | 7 | |
Sodium nitroprusside releases NO, which can modulate various cellular signaling pathways and enhance the activity of membrane transporters like MFSD6 by affecting membrane fluidity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, which regulates cellular metabolism and can enhance the activity of transport proteins such as MFSD6 by modulating cellular energy status. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $153.00 $520.00 | 4 | |
CHIR99021 inhibits GSK3, altering cellular pathways that can upregulate transport processes and potentially enhance the functional activity of MFSD6. |